Biochemical and clinical changes during enzymatic replacement therapy in hypophosphatasia: three real-world cases in Spain.
Three patients with a rare bone disease showed substantial symptom improvement and better daily functioning after enzyme replacement therapy.
This case series described biochemical and clinical changes during enzyme replacement therapy in three Spanish patients with hypophosphatasia. All three patients responded well to asfotase alfa, with substantial improvements in symptoms and daily functioning.
What the study was
- Study design
- Real-world case series (rare disease)
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Drugs in context
Why it surfaced
High triage score (8/10) based on study design (Real-world case series (rare disease)) and direct clinical relevance; matched topic: Rare diseases with high unmet need; flag: 🟡 Underserved or high-risk populations
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.